Your browser doesn't support javascript.
loading
Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.
Devaud, Christel; Westwood, Jennifer A; John, Liza B; Flynn, Jacqueline K; Paquet-Fifield, Sophie; Duong, Connie P M; Yong, Carmen S M; Pegram, Hollie J; Stacker, Steven A; Achen, Marc G; Stewart, Trina J; Snyder, Linda A; Teng, Michele W L; Smyth, Mark J; Darcy, Phillip K; Kershaw, Michael H.
Afiliação
  • Devaud C; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Westwood JA; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • John LB; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Flynn JK; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Paquet-Fifield S; Tumor Angiogenesis Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Duong CP; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Yong CS; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Pegram HJ; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Stacker SA; Tumor Angiogenesis Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Achen MG; Tumor Angiogenesis Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Stewart TJ; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Snyder LA; Janssen Research and Development, Radnor, Pennsylvania, USA.
  • Teng MW; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Smyth MJ; Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Darcy PK; 1] Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia [2] Department of Immunology, Monash University, Prahran, Victoria, Australia.
  • Kershaw MH; 1] Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia [2] Department of Immunology, Monash University, Prahran, Victoria, Australia.
Mol Ther ; 22(1): 18-27, 2014 Jan.
Article em En | MEDLINE | ID: mdl-24048441

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_colon_rectum_cancers / 6_kidney_renal_pelvis_ureter_cancer Assunto principal: Microambiente Tumoral / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_colon_rectum_cancers / 6_kidney_renal_pelvis_ureter_cancer Assunto principal: Microambiente Tumoral / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Austrália
...